Abstract
The relationship between tumour stage, grade, elevated C-reactive protein concentration (<10/>10 mg l(-1)), adjuvant therapy and survival was examined in patients with biopsy proven bladder cancer (n=105). On multivariate analysis stage (HR 3.37, 95% CI 1.37-8.29, P=0.008), grade (HR 2.01, 95% CI 1.14-3.57, P=0.017) and preoperative C-reactive protein (HR 3.31, 95% CI 1.09-10.09, P=0.035) were independently associated with cancer-specific survival.
MeSH terms
-
Aged
-
Analysis of Variance
-
C-Reactive Protein / metabolism
-
Carcinoma, Transitional Cell / blood
-
Carcinoma, Transitional Cell / complications*
-
Carcinoma, Transitional Cell / mortality*
-
Carcinoma, Transitional Cell / pathology
-
Carcinoma, Transitional Cell / therapy
-
Confidence Intervals
-
Disease-Free Survival
-
Female
-
Humans
-
Male
-
Middle Aged
-
Odds Ratio
-
Survival Analysis
-
Systemic Inflammatory Response Syndrome / blood
-
Systemic Inflammatory Response Syndrome / complications*
-
Systemic Inflammatory Response Syndrome / mortality*
-
Urinary Bladder Neoplasms / blood
-
Urinary Bladder Neoplasms / complications*
-
Urinary Bladder Neoplasms / mortality*
-
Urinary Bladder Neoplasms / pathology
-
Urinary Bladder Neoplasms / therapy